← Leaderboards
Fernando Ovalle
University Of Alabama At Birmingham
$19,690
Attributed
$19,690
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$19,690 · 3
By mechanism
M01$19,690 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Bradley K. Yoder$32,312,462
- Michael I Goran$47,330,547
- Ricardo Azziz$5,301,766
- Barbara A. Gower$29,302,489
- Lisa Marie Guay-Woodford$63,706,776
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchFemalePatient Oriented ResearchClinical Trial Phase IComorbidityDiabetes Mellitus GeneticsDiabetes Mellitus TherapyDisease /Disorder Prevention /ControlDisease /Disorder Proneness /RiskDrug Screening /EvaluationFamily GeneticsGenetic ScreeningGenetic SusceptibilityGlucose Clamp TechniqueHormone BiosynthesisHuman Therapy EvaluationInsulinInsulin Dependent Diabetes MellitusInsulin Sensitivity /ResistanceLongitudinal Human StudyNoninsulin Dependent Diabetes MellitusPolycystic KidneyPolycystic Ovary Syndrome
Grant awards (5)
THE RISK OF THE POLYCYSTIC OVARY SYNDROME IN WOMEN WITH TYPE 2 DIABETES MELLITUS$3,498
M01 · FY2005 · RR
ADRENICORTICAL STEROIDOGENESIS IN EUANDROGENIC AND HYPERANDROGENIC WOMEN$1,249
M01 · FY2005 · RR
The Risk of the Polycystic Ovary Syndrome in Women$14,389
M01 · FY2004 · RR
Adrenicortical steroidogen. in eu/hyperandrogenic women$554
M01 · FY2004 · RR
DIABETES PREVENTION TRIAL: TYPE I (DPT-1)$0
M01 · FY2000 · RR